In this study, we observed that the mRNA and protein expressions of key inflammatory pathway molecules, including TLR4, MYD88, and IL-6, were significantly upregulated in the kidneys of the LN mouse model, and were down-regulated with the improvement of renal inflammation after DNase I treatment. This evidence concerns the gene TLR4 and lobular neoplasia.